Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation

In a paper published in the New England Journal of Medicine, Mass General Brigham researchers report that a new class of drugs significantly reduced bleeding events compared with standard-of-care treatment

2025-01-22

(Press-News.org) Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to concerns of increased risk of bleeding complications. Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial was stopped early by the recommendation of the Data Monitoring Committee due to an overwhelming reduction in bleeding compared to standard-of-care treatment. The researchers report in the New England Journal of Medicine that abelacimab, a Factor XI inhibitor, significantly reduced bleeding compared to a standard-of-care anticoagulant, rivaroxaban.

“It should be enormously satisfying to the cardiovascular field, patients and providers that Factor XI inhibitors live up to their promise of superior safety," said Christian Ruff, MD, MPH, director of General Cardiology within the Cardiovascular Division at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, senior investigator in the TIMI Study Group and principal investigator of the AZALEA-TIMI 71 Study. “Atrial fibrillation is a common medical condition, and bleeding with currently available anticoagulants resulting in significant undertreatment is still one of the greatest shortcomings in cardiovascular disease.”

About 1-in-3 people will develop atrial fibrillation, making it one of the most common cardiovascular conditions in the world. The risk of stroke increases significantly in patients with atrial fibrillation because blood clots form in the heart chambers and can be pumped to the brain, causing a stroke.

The AZALEA-TIMI 71 Study is the largest and longest trial examining a Factor XI inhibitor compared to standard of care direct oral anticoagulants to date. The team enrolled 1,287 participants in 95 study sites across the globe. Participants were randomized and administered monthly injections of 150 mg abelacimab, 90 mg abelacimab, or standard dosing of rivaroxaban (20 mg or 15 mg in dose reduced patients). The team found that the 150 mg dose of abelacimab reduced bleeding that required hospitalization or medical attention by 62%, compared with rivaroxaban. The 90 mg dose of abelacimab reduced the same types of bleeding by 69%. In addition, the team found that both doses of abelacimab almost eliminated gastrointestinal bleeding compared to rivaroxaban, which is the most common type of bleeding that occurs in patients on currently available anticoagulants.

The team notes that in the AZALEA-TIMI 71 Study, the rates of stroke were low and there were not any significant differences between patients in the abelacimab groups compared to those taking rivaroxaban, although the trial was not powered for ischemic events.

The TIMI Study Group is leading an ongoing phase 3 trial of the study, LILAC-TIMI 76, which will compare the 150 mg dose of abelacimab to placebo in high-risk atrial fibrillation patients who have been deemed ineligible for current anticoagulants for the prevention of ischemic stroke and systemic embolism.

“The AZALEA-TIMI 71 Study validated that Factor XI inhibitors have an incredibly safe bleeding profile in patients with atrial fibrillation, which is a tremendous potential advance for our patients,” said Ruff. “Now we can shift our attention as we await the results of the phase 3 trials.”

Authorship: In addition to Ruff, Mass General Brigham authors of the study include Siddharth M. Patel, Robert P. Giugliano, David A. Morrow, Julia F. Kuder, Erica L. Goodrich, Sabina A. Murphy, Stephen D. Wiviott, and Marc S. Sabatine.

Disclosures: The TIMI Study Group which as received institutional research grant support through Brigham and Women’s Abbott, Abiomed, Inc., Amgen, Anthos Therapeutics, ARCA Biopharma, Inc., AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Ionis Pharmaceuticals, Inc., Janssen Research and Development, LLC, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Roche, Saghmos Therapeutics, Inc., Siemens Healthcare Diagnostics, Inc., Softcell Medical Limited, The Medicines Company, Verve Therapeutics, Inc., and Zora Biosciences.

Funding: The AZALEA-TIMI 71 trial was sponsored by Anthos Therapeutics.

Paper cited: Ruff CT et al. “Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation” New England Journal of Medicine DOI: 10.1056/NEJMoa2406674

###

About Mass General Brigham

Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.

END

ELSE PRESS RELEASES FROM THIS DATE:

UMaine-led team develops more holistic way to monitor lobster industry

2025-01-22

Maine’s lobster fishery — one that supports thousands of jobs statewide — is extensively monitored. Management efforts are informed by biological monitoring surveys observing changes in abundance and distribution of the lobster population, and dealer and harvester reporting from the industry. Yet these statistics don't tell the whole story of an industry shaken by supply and market disruptions and geopolitical conflict, or the welfare of the people and communities that rely on ...

Antiviral protein causes genetic changes implicated in Huntington’s disease progression

2025-01-22

People genetically susceptible to Huntington’s disease often see their movement, mood, and cognition decline slowly over time. The cause is related to expansion of repeating DNA units, in which specific strings of genetic code—in this case, a series of cytosine-adenine-guanine nucleotides, or CAG, on one strand of the DNA and cytosine-thymine-guanine, or CTG, on the complementary strand—begin to repeat over and over, expanding to as many as 40 to 120 copies. The extended copies create kinks in the DNA, making it more susceptible ...

SwRI-led PUNCH spacecraft make final pit stop before launch

2025-01-22

SAN ANTONIO — January 22, 2025 —Four small suitcase-sized spacecraft, designed and built by Southwest Research Institute, have made a final Earth-side pit stop at Vandenberg Space Force Base in California. NASA’s Polarimeter to Unify the Corona and Heliosphere, or PUNCH, mission is sharing a ride to space with the Spectro-Photometer for the History of the Universe, Epoch of Reionization and Ices Explorer (SPHEREx) observatory. “The PUNCH mission will integrate our understanding of the Sun’s corona, the outer atmosphere ...

Claims for the world’s deepest earthquake challenged by new analysis

2025-01-22

The magnitude 7.9 Bonin Islands earthquake sequence, which ruptured deep within the earth near the base of the upper mantle, did not include an aftershock that extended to record depths into the lower mantle, according to a study in The Seismic Record. When Hao Zhang of the University of Southern California and colleagues re-examined the aftershock sequence of the May 2015 earthquake, they did not find evidence for a 751-kilometer-deep aftershock as reported by previous researchers. This aftershock has been called the deepest earthquake ever recorded. Instead, their study found a distribution of aftershocks that is compatible with a 12-kilometer sliver of a mantle mineral called olivine ...

MSU study finds children of color experience more variability in sleep times

2025-01-22

MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request. EAST LANSING, Mich. – Researchers from Michigan State University’s Department of Human Development and Family Studies revealed that sleep patterns may vary across different racial and ethnic groups — notably for non-white and multiracial children. Yijie Wang is an associate professor of human development and family studies in the College of Social Science, and her research team published a ...

Pregnancy may increase risk of mental illness in people with MS

2025-01-22

MINNEAPOLIS — Pregnant people with multiple sclerosis (MS) have a higher chance of experiencing mental illness both during their pregnancy and in the first years after they give birth than those without MS, according to a study published in the January 22, 2025 online issue of Neurology®, the medical journal of the American Academy of Neurology. “Previous studies have shown that women with MS are more likely to have depression, anxiety disorders and bipolar disorder compared to women without MS,” said study author Ruth Ann Marrie, MD, PhD, of Dalhousie University in Halifax, Canada, and ...

Multiple sclerosis linked to higher risk of mental illness during and after pregnancy

2025-01-22

Toronto, ON, January 22, 2025 – People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births in Ontario. The research, published online in Neurology, the medical journal of the American Academy of Neurology, sheds light on the mental health challenges faced by people with MS during pregnancy and the first year after childbirth. Using population-based health ...

Beyond ChatGPT: WVU researchers to study use and ethics of artificial intelligence across disciplines

2025-01-22

Two West Virginia University researchers have designed a curriculum to engage liberal arts faculty in discussions on the social, ethical and technical aspects of artificial intelligence and its role in classrooms. Through a grant from the National Endowment for the Humanities, Erin Brock Carlson, assistant professor of English, and Scott Davidson, professor of philosophy, both at the WVU Eberly College of Arts and Sciences, have designed an interdisciplinary, cross-institutional program to facilitate conversations among faculty about the ...

Ultrasensitive test detects, serially monitors intact virus levels in patients with COVID-19

2025-01-22

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients. The research is published in Science Advances. “During the early days of the pandemic, we wanted to see if our approach for isolating small cancer vesicles could be adapted to isolate SARS-CoV-2 virus from biofluids like blood, stool, and ...

mRNA-activated blood clots could cushion the blow of osteoarthritis

2025-01-22

MADISON — University of Wisconsin–Madison researchers have developed a promising technique for treating osteoarthritis using therapeutic blood clots activated by messenger RNA. Osteoarthritis is the most common form of arthritis, affecting roughly 33 million adults in the United States, according to the Centers for Disease Control and Prevention. It occurs when cartilage in key joints like the knees and hips deteriorates, causing pain and stiffness and impeding mobility. In a paper in the journal Bioactive Materials ...

LAST 30 PRESS RELEASES:

New, embodied AI reveals how robots and toddlers learn to understand

Game, set, match: Exploring the experiences of women coaches in tennis

Significant rise in mental health admissions for young people in last decade

Prehab shows promise in improving health, reducing complications after surgery

Exercise and improved diet before surgery linked to fewer complications and enhanced recovery

SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission

Could the Summerville ghost lantern be an earthquake light?

Will the U.S. have enough pain specialists?

Stronger stress response in monkeys helps them survive

Using infrared heat transfer to modify chemical reactions

Being a ladies' man comes at a price for alpha male baboons